Spontaneous versus spontaneous timed mode of assisted ventilation in patients with chest wall disease and stable neuromuscular disease
Institute for Breathing And Sleep
20 participants
May 1, 2008
Interventional
Conditions
Summary
The study aims to compare 2 commonly used modes of ventilation in patients with respiratory failure from neuromuscular disease or chest wall disease such as kyphoscoliosis. The study population will be patients already on mechanical ventilation to assist their breathing. As there is no current evidence that one treatment is better than the other, we wish to study the 2 ventilation modes in a crossover design (i.e. one treatment will be followed by the other on each patient) with regards to efficacy of ventilation and sleep quality on each mode. The study hypothesis is that there is no difference between the 2 modes (called the null hypothesis). The study will then attempt to prove whether this is true (i.e. accept the null hypothesis meaning that there is no difference), or false (i.e. reject the null hypothesis meaning that there is a difference between the 2 modes ). The study will help in the long term to determine which mode is more efficacious and comfortable to the patients with neuromuscular or chest wall disease.
Eligibility
Plain Language Summary
Simplified for easier understanding
This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
We aim to compare 2 commonly used modes of ventilation in patients with respiratory failure from either neuromuscular disease or chest wall disease, such as kyphoscoliosis. The first mode is called "spontaneous mode of pressure supported mechanical ventilation"; where the patient would trigger the ventilator totally on his/ her own; and the second is called "spontaneous timed mode of pressure supported mechanical ventilation"; where the ventilator has a set breath rate but also allows him or her to trigger the ventilator as required. The target population are patients with respiratory failure from neuromuscular disease and chest wall disease, who are already on mechanical ventilation usually in one of these 2 modes described. The patients will remain on each mode of ventilation for a period of 2 weeks, which is followed by a sleep study to assess efficacy of ventilation and sleep quality on each mode. They will also fill out a standardised questionnaire asking them, which mode caused any discomfort, and which one they prefered?. A washout period of 2 weeks will follow the initial mode when the participants will go back on their original ventilator.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12608000103369